What Know About This Fund's Indivior Sale: $74.8M Analysis
A major hedge fund reduced its Indivior stake by more than 2.2 million shares, signaling a shift in positioning. This...
This piece outlines scenarios where a lifecycle fund may be preferable to a target date fund, helping you tailor your retirement strategy.
23,134 articlesA major hedge fund reduced its Indivior stake by more than 2.2 million shares, signaling a shift in positioning. This...
A major fund recently sold its entire NIO position for about $79.8 million. This article breaks down what happened, w...
HeartBeam heads into 2025 earnings with a mix of potential breakthroughs and headwinds. This guide explains what the ...
When a living legend weighs in on modern fame, it isn’t just a music moment. It’s a money moment. This article breaks...
As offshore energy demand shifts, investors face a clear choice: TechnipFMC or Valaris. This guide breaks down how ea...
A five-year plumbing dispute in a premium Manhattan co-op escalates into questions about the building’s finances. Thi...
When insider-like conviction meets market risk, funds can double down on a stock. This analysis explains why Black Cy...
RunSybil secures $40 million in a funding round led by Khosla Ventures, backing its autonomous AI agents that hack li...
Li Lu’s Himalaya Capital places a near alarmingly large bet on Alphabet, powering a dramatic year for the fund and re...
A boutique investor firm makes a bold healthcare bet by accumulating over 2 million Baxter International shares. The ...
Investors are reassessing opportunities in firearm makers as policy shifts and demand cycles test the staying power o...
Decades of secrecy around cutting-edge defense programs are giving way to public scrutiny and market reassessment. In...